AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Genenta Science S.p.A.

$0.88 -$0.53 (-37.94%)
NASDAQ · 15 Sep 2026 14:23 UTC
Previous Close
$0.83
Day Range
$0.83$0.88
Year Range
$0.55$10
Market Cap
16.76M
AVG Volume
1.04M
Trailing/Forward PE
-2.3/-
PEG ratio
-0.15
Dividend Yield
-
Next Earnings Date
2027-03-03
Primary Exchange
NASDAQUS
Net Income (EUR)
-8M-6M-4M-2M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Net Income (EUR) by quarter
PeriodNet Income (EUR)
25 Q4-2.68M
25 Q2-3.57M
24 Q4-5.1M
24 Q2-4.07M
23 Q4-4.8M
23 Q2-6.7M
22 Q4-6.37M
22 Q2-2.11M
21 Q4-1.48M
21 Q2-4.05M
Operating Income (EUR)
-8M-6M-4M-2M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Operating Income (EUR) by quarter
PeriodOperating Income (EUR)
25 Q4-3.2M
25 Q2-3.15M
24 Q4-5.48M
24 Q2-4.55M
23 Q4-4.85M
23 Q2-6.74M
22 Q4-6.89M
22 Q2-4.15M
21 Q4-1.65M
21 Q2-4.04M
EBITDA (EUR)
-8M-6M-4M-2M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA EBITDA (EUR) by quarter
PeriodEBITDA (EUR)
25 Q4-2.66M
25 Q2-3.19M
24 Q4-5.07M
24 Q2-4.05M
23 Q4-4.78M
23 Q2-6.68M
22 Q4-6.36M
22 Q2-2.11M
21 Q4-1.48M
21 Q2-4.05M
Cash Flows (EUR)
-8M-6M-4M-2M021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Cash Flows (EUR) by quarter
PeriodCash Flows (EUR)
25 Q4-1.69M
25 Q2-6.03M
24 Q4-6.24M
24 Q2-2.06K
23 Q4-3.63K
23 Q2-7.52M
22 Q4-4.88M
22 Q2-2.57M
21 Q4-2.27M
21 Q2-4.69M
EPS (EUR)
-0.4-0.3-0.2-0.1-021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA EPS (EUR) by quarter
PeriodEPS (EUR)
25 Q4-0.13
25 Q2-0.2
24 Q4-0.27
24 Q2-0.22
23 Q4-0.27
23 Q2-0.37
22 Q4-0.34
22 Q2-0.12
21 Q4-0.1
21 Q2-0.28
Expenses (EUR)
02M4M6M8MR&DSG&ACapex21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Expenses (EUR) by quarter
PeriodExpenses (EUR)
25 Q43.18M
25 Q23.15M
24 Q45.47M
24 Q24.53M
23 Q44.83M
23 Q26.73M
22 Q46.91M
22 Q24.16M
21 Q41.65M
21 Q24.05M
Cash & Debt (EUR)
010M20M30M40MCashLong Term Debt21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Cash & Debt (EUR) by quarter
PeriodCash & Debt (EUR)
25 Q428.15M
25 Q217.67M
24 Q412.66M
24 Q216.91M
23 Q418.78M
23 Q222.21M
22 Q429.79M
22 Q234.67M
21 Q437.24M
21 Q210.55M
Debt ratios
0123421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Debt ratios by quarter
PeriodDebt ratios
25 Q41.37
25 Q20.59
24 Q40.61
24 Q20.77
23 Q40.94
23 Q21.34
22 Q42.13
22 Q23.23
21 Q43.35
21 Q21.1
Return on Capital
-60%-40%-20%0%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Return on Capital by quarter
PeriodReturn on Capital
25 Q4-12.29%
25 Q2-29.45%
24 Q4-40.78%
24 Q2-24.19%
23 Q4-23.51%
23 Q2-27%
22 Q4-20.44%
22 Q2-5.71%
21 Q4-3.81%
21 Q2-34.89%
Shares Outstanding
010M20M30M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Shares Outstanding by quarter
PeriodShares Outstanding
25 Q421.22M
25 Q218.77M
24 Q418.29M
24 Q218.26M
23 Q418.22M
23 Q218.22M
22 Q418.22M
22 Q218.22M
21 Q415.39M
21 Q214.77M
Book Value Per Share (EUR)
012321 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Book Value Per Share (EUR) by quarter
PeriodBook Value Per Share (EUR)
25 Q41.03
25 Q20.65
24 Q40.68
24 Q20.92
23 Q41.12
23 Q21.36
22 Q41.71
22 Q22.03
21 Q42.52
21 Q20.79
Total Assets (EUR)
020M40M60M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
GNTA Total Assets (EUR) by quarter
PeriodTotal Assets (EUR)
25 Q431.89M
25 Q221.55M
24 Q414.82M
24 Q219.02M
23 Q422.35M
23 Q226.73M
22 Q433.44M
22 Q238.28M
21 Q440.03M
21 Q213.29M
Employee Count
05101520212022202320242025
GNTA Employee Count by quarter
PeriodEmployee Count
20259
202413
202314
20229
20217
Free Cash Flow Yield
-150%-100%-50%0%med -28.41%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GNTA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-91.85%
Sep 26-90.84%
Sep 26-79.67%
Aug 26-76.28%
Aug 26-61.03%
Aug 26-58.59%
Aug 26-58.54%
Jul 26-50.95%
Jul 26-47.09%
Jul 26-48.59%
Jul 26-50.11%
Jul 26-43.77%
Jun 26-41.41%
Jun 26-44.92%
Jun 26-40.73%
Jun 26-37.18%
May 26-74.5%
May 26-131.7%
May 26-121.91%
May 26-123.94%
May 26-105.71%
Apr 26-108.98%
Apr 26-106.13%
Apr 26-115.41%
Apr 26-107.05%
Mar 26-106.14%
Mar 26-120.08%
Mar 26-85.07%
Mar 26-88.41%
Feb 26-78.11%
Feb 26-77.14%
Feb 26-88.28%
Feb 26-105.64%
Jan 26-78.63%
Jan 26-58.21%
Jan 26-58.4%
Jan 26-53.63%
Jan 26-54.4%
Dec 25-52.77%
Dec 25-52.85%
Dec 25-54.49%
Dec 25-40.74%
Nov 25-37.76%
Nov 25-44.85%
Nov 25-35.05%
Nov 25-32.91%
Oct 25-29.49%
Oct 25-12.28%
Oct 25-23.98%
Oct 25-23.41%
Oct 25-26.8%
Sep 25-27.88%
Sep 25-30.92%
Sep 25-29.94%
Sep 25-25.21%
Aug 25-23.41%
Aug 25-25.15%
Aug 25-25.19%
Aug 25-23.63%
Aug 25-22.84%
Jul 25-23.39%
Jul 25-23.22%
Jul 25-22.23%
Jul 25-23.3%
Jun 25-28.46%
Jun 25-28.36%
Jun 25-22.42%
Jun 25-21.45%
May 25-18.99%
May 25-20.38%
May 25-19.78%
May 25-19.52%
May 25-21.43%
Apr 25-21.19%
Apr 25-22.07%
Apr 25-23.45%
Apr 25-22.87%
Mar 25-20.56%
Mar 25-17.71%
Mar 25-19.33%
Mar 25-19.37%
Feb 25-18.08%
Feb 25-17.95%
Feb 25-16.32%
Feb 25-18.33%
Jan 25-20%
Jan 25-17.18%
Jan 25-18.56%
Jan 25-14.66%
Jan 25-16.14%
Dec 24-14.52%
Dec 24-14.15%
Dec 24-13.91%
Dec 24-13.68%
Nov 24-13.82%
Nov 24-15.1%
Nov 24-14.27%
Nov 24-14.87%
Nov 24-13.52%
Oct 24-14.06%
Price to Book
0246810med 3.75Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
GNTA Price to Book by quarter
PeriodPrice to Book
Sep 260.7
Sep 260.7
Sep 260.8
Aug 260.84
Aug 261.05
Aug 261.09
Aug 261.09
Jul 261.26
Jul 261.36
Jul 261.32
Jul 261.28
Jul 261.46
Jun 261.54
Jun 261.42
Jun 261.57
Jun 261.72
May 260.86
May 260.49
May 260.52
May 260.52
May 260.6
Apr 260.59
Apr 260.6
Apr 260.55
Apr 260.6
Mar 260.96
Mar 260.84
Mar 261.19
Mar 261.15
Feb 261.3
Feb 261.31
Feb 261.15
Feb 260.96
Jan 261.29
Jan 261.74
Jan 261.74
Jan 261.89
Jan 261.86
Dec 251.92
Dec 251.92
Dec 251.86
Dec 252.49
Nov 252.68
Nov 252.26
Nov 252.89
Nov 253.08
Oct 253.44
Oct 258.26
Oct 254.23
Oct 254.33
Oct 254.11
Sep 253.95
Sep 253.56
Sep 253.68
Sep 254.37
Aug 254.71
Aug 254.38
Aug 254.38
Aug 254.66
Aug 254.83
Jul 254.71
Jul 254.75
Jul 254.96
Jul 254.73
Jun 253.87
Jun 253.89
Jun 254.92
Jun 255.14
May 255.8
May 255.41
May 255.57
May 255.65
May 255.14
Apr 255.2
Apr 254.99
Apr 254.7
Apr 254.82
Mar 255.36
Mar 254.16
Mar 253.82
Mar 253.81
Feb 254.08
Feb 254.11
Feb 254.52
Feb 254.02
Jan 253.69
Jan 254.29
Jan 253.97
Jan 255.03
Jan 254.57
Dec 245.08
Dec 245.21
Dec 245.3
Dec 245.39
Nov 245.34
Nov 244.89
Nov 245.17
Nov 244.96
Nov 245.46
Oct 245.25
Genenta Science S.p.A.
GNTA
Stockpicker

Video analysis: GNTA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: GNTA

Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit

globenewswire.com · 15 Sep 2026

Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit

The Spring Assembly manufactured by Sòphia HT, a strategic Genenta investment, supports the separation of the launcher's second and third stages Sòphia HT has been in serial production of the component since 2018 MILAN, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A.

Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm

globenewswire.com · 23 Jul 2026

Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm

MILAN and NAPLES, Italy, July 23, 2026 (GLOBE NEWSWIRE) -- Sòphia High Tech S.r.l. (Sòphia HT), an Italian aerospace and defense company manufacturing critical parts for Europe's space and defense programs, backed by Genenta Science S.p.A.

Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results

globenewswire.com · 22 Jul 2026

Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results

Fiscal Year 2025 Highlights FY2025 sales rose 29.3% to €7.17 million; total value of production increased 34.7% to €8.47 million EBITDA grew 68.1% to €1.61 million, expanding the EBITDA margin by approximately 380 basis points to 19.0% Operating profit advanced 80.8% to €1.21 million MILAN, July 22, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on aerospace, defense, biotech and Italian national-security-related technologies, today announced that the Board of Directors of Sòphia High Tech S.r.l.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.